Global Biosimilar Development Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR022401832

Publication Date:

February 22, 2024

Pages:

115

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global Biosimilar Development Services market size was valued at USD 113430 million in 2023 and is forecast to a readjusted size of USD 220380 million by 2030 with a CAGR of 10.0% during review period.
The main contents of Biosimilar Development Services include drug design and screening, pharmacodynamic research, pharmaceutical research, pharmacokinetic research, clinical trial program design and implementation, production process development and verification, etc. These services are designed to ensure that biosimilars are similar or identical to reference medicines in terms of mechanism of action, strength, dosage, safety and effectiveness.
With the rise of personalized medicine, Biosimilar Development will pay more attention to the specific needs of patients and conduct customized development for different patient groups to improve treatment effects and meet personalized needs.
With the rise of personalized medicine, Biosimilar Development will pay more attention to the specific needs of patients and conduct customized development for different patient groups to improve treatment effects and meet personalized needs.
This report includes an overview of the development of the Biosimilar Development Services industry chain, the market status of Cancer (Insulin, Anti-Cancer Drugs), Diabetes (Insulin, Anti-Cancer Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar Development Services.
Regionally, the report analyzes the Biosimilar Development Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar Development Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar Development Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar Development Services industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Insulin, Anti-Cancer Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar Development Services market.
Regional Analysis: The report involves examining the Biosimilar Development Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar Development Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar Development Services:
Company Analysis: Report covers individual Biosimilar Development Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar Development Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Diabetes).
Technology Analysis: Report covers specific technologies relevant to Biosimilar Development Services. It assesses the current state, advancements, and potential future developments in Biosimilar Development Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar Development Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar Development Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Insulin
Anti-Cancer Drugs
Others
Market segment by Application
Cancer
Diabetes
Arthritis
Psoriasis
Neutropenia
Enzyme or Hormone Deficiency
Others
Market segment by players, this report covers
3P Bio
BioPharmaSpec
Charles River Laboratories
ICON
Intertek
JSR Life Sciences
Labcorp
Syneos Health
PPD Inc
Profacgen
Sartorius
SGS S.A.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biosimilar Development Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilar Development Services, with revenue, gross margin and global market share of Biosimilar Development Services from 2019 to 2024.
Chapter 3, the Biosimilar Development Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Biosimilar Development Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilar Development Services.
Chapter 13, to describe Biosimilar Development Services research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope of Biosimilar Development Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biosimilar Development Services by Type
1.3.1 Overview: Global Biosimilar Development Services Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Biosimilar Development Services Consumption Value Market Share by Type in 2023
1.3.3 Insulin
1.3.4 Anti-Cancer Drugs
1.3.5 Others
1.4 Global Biosimilar Development Services Market by Application
1.4.1 Overview: Global Biosimilar Development Services Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cancer
1.4.3 Diabetes
1.4.4 Arthritis
1.4.5 Psoriasis
1.4.6 Neutropenia
1.4.7 Enzyme or Hormone Deficiency
1.4.8 Others
1.5 Global Biosimilar Development Services Market Size & Forecast
1.6 Global Biosimilar Development Services Market Size and Forecast by Region
1.6.1 Global Biosimilar Development Services Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Biosimilar Development Services Market Size by Region, (2019-2030)
1.6.3 North America Biosimilar Development Services Market Size and Prospect (2019-2030)
1.6.4 Europe Biosimilar Development Services Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Biosimilar Development Services Market Size and Prospect (2019-2030)
1.6.6 South America Biosimilar Development Services Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Biosimilar Development Services Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 3P Bio
2.1.1 3P Bio Details
2.1.2 3P Bio Major Business
2.1.3 3P Bio Biosimilar Development Services Product and Solutions
2.1.4 3P Bio Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 3P Bio Recent Developments and Future Plans
2.2 BioPharmaSpec
2.2.1 BioPharmaSpec Details
2.2.2 BioPharmaSpec Major Business
2.2.3 BioPharmaSpec Biosimilar Development Services Product and Solutions
2.2.4 BioPharmaSpec Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioPharmaSpec Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Biosimilar Development Services Product and Solutions
2.3.4 Charles River Laboratories Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 ICON
2.4.1 ICON Details
2.4.2 ICON Major Business
2.4.3 ICON Biosimilar Development Services Product and Solutions
2.4.4 ICON Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ICON Recent Developments and Future Plans
2.5 Intertek
2.5.1 Intertek Details
2.5.2 Intertek Major Business
2.5.3 Intertek Biosimilar Development Services Product and Solutions
2.5.4 Intertek Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Intertek Recent Developments and Future Plans
2.6 JSR Life Sciences
2.6.1 JSR Life Sciences Details
2.6.2 JSR Life Sciences Major Business
2.6.3 JSR Life Sciences Biosimilar Development Services Product and Solutions
2.6.4 JSR Life Sciences Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 JSR Life Sciences Recent Developments and Future Plans
2.7 Labcorp
2.7.1 Labcorp Details
2.7.2 Labcorp Major Business
2.7.3 Labcorp Biosimilar Development Services Product and Solutions
2.7.4 Labcorp Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Labcorp Recent Developments and Future Plans
2.8 Syneos Health
2.8.1 Syneos Health Details
2.8.2 Syneos Health Major Business
2.8.3 Syneos Health Biosimilar Development Services Product and Solutions
2.8.4 Syneos Health Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Syneos Health Recent Developments and Future Plans
2.9 PPD Inc
2.9.1 PPD Inc Details
2.9.2 PPD Inc Major Business
2.9.3 PPD Inc Biosimilar Development Services Product and Solutions
2.9.4 PPD Inc Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 PPD Inc Recent Developments and Future Plans
2.10 Profacgen
2.10.1 Profacgen Details
2.10.2 Profacgen Major Business
2.10.3 Profacgen Biosimilar Development Services Product and Solutions
2.10.4 Profacgen Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Profacgen Recent Developments and Future Plans
2.11 Sartorius
2.11.1 Sartorius Details
2.11.2 Sartorius Major Business
2.11.3 Sartorius Biosimilar Development Services Product and Solutions
2.11.4 Sartorius Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Sartorius Recent Developments and Future Plans
2.12 SGS S.A.
2.12.1 SGS S.A. Details
2.12.2 SGS S.A. Major Business
2.12.3 SGS S.A. Biosimilar Development Services Product and Solutions
2.12.4 SGS S.A. Biosimilar Development Services Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 SGS S.A. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biosimilar Development Services Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Biosimilar Development Services by Company Revenue
3.2.2 Top 3 Biosimilar Development Services Players Market Share in 2023
3.2.3 Top 6 Biosimilar Development Services Players Market Share in 2023
3.3 Biosimilar Development Services Market: Overall Company Footprint Analysis
3.3.1 Biosimilar Development Services Market: Region Footprint
3.3.2 Biosimilar Development Services Market: Company Product Type Footprint
3.3.3 Biosimilar Development Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biosimilar Development Services Consumption Value and Market Share by Type (2019-2024)
4.2 Global Biosimilar Development Services Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Biosimilar Development Services Consumption Value Market Share by Application (2019-2024)
5.2 Global Biosimilar Development Services Market Forecast by Application (2025-2030)
6 North America
6.1 North America Biosimilar Development Services Consumption Value by Type (2019-2030)
6.2 North America Biosimilar Development Services Consumption Value by Application (2019-2030)
6.3 North America Biosimilar Development Services Market Size by Country
6.3.1 North America Biosimilar Development Services Consumption Value by Country (2019-2030)
6.3.2 United States Biosimilar Development Services Market Size and Forecast (2019-2030)
6.3.3 Canada Biosimilar Development Services Market Size and Forecast (2019-2030)
6.3.4 Mexico Biosimilar Development Services Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Biosimilar Development Services Consumption Value by Type (2019-2030)
7.2 Europe Biosimilar Development Services Consumption Value by Application (2019-2030)
7.3 Europe Biosimilar Development Services Market Size by Country
7.3.1 Europe Biosimilar Development Services Consumption Value by Country (2019-2030)
7.3.2 Germany Biosimilar Development Services Market Size and Forecast (2019-2030)
7.3.3 France Biosimilar Development Services Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Biosimilar Development Services Market Size and Forecast (2019-2030)
7.3.5 Russia Biosimilar Development Services Market Size and Forecast (2019-2030)
7.3.6 Italy Biosimilar Development Services Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Development Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Biosimilar Development Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Biosimilar Development Services Market Size by Region
8.3.1 Asia-Pacific Biosimilar Development Services Consumption Value by Region (2019-2030)
8.3.2 China Biosimilar Development Services Market Size and Forecast (2019-2030)
8.3.3 Japan Biosimilar Development Services Market Size and Forecast (2019-2030)
8.3.4 South Korea Biosimilar Development Services Market Size and Forecast (2019-2030)
8.3.5 India Biosimilar Development Services Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Biosimilar Development Services Market Size and Forecast (2019-2030)
8.3.7 Australia Biosimilar Development Services Market Size and Forecast (2019-2030)
9 South America
9.1 South America Biosimilar Development Services Consumption Value by Type (2019-2030)
9.2 South America Biosimilar Development Services Consumption Value by Application (2019-2030)
9.3 South America Biosimilar Development Services Market Size by Country
9.3.1 South America Biosimilar Development Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Biosimilar Development Services Market Size and Forecast (2019-2030)
9.3.3 Argentina Biosimilar Development Services Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Development Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Biosimilar Development Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Biosimilar Development Services Market Size by Country
10.3.1 Middle East & Africa Biosimilar Development Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Biosimilar Development Services Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Biosimilar Development Services Market Size and Forecast (2019-2030)
10.3.4 UAE Biosimilar Development Services Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Biosimilar Development Services Market Drivers
11.2 Biosimilar Development Services Market Restraints
11.3 Biosimilar Development Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Biosimilar Development Services Industry Chain
12.2 Biosimilar Development Services Upstream Analysis
12.3 Biosimilar Development Services Midstream Analysis
12.4 Biosimilar Development Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

3P Bio
BioPharmaSpec
Charles River Laboratories
ICON
Intertek
JSR Life Sciences
Labcorp
Syneos Health
PPD Inc
Profacgen
Sartorius
SGS S.A.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂